DT2216-a Bcl-xL-specific degrader is highly active against Bcl-xL-dependent T cell lymphomas.

Journal of Hematology & Oncology
Yonghan HeDaohong Zhou

Abstract

Patients with advanced T cell lymphomas (TCLs) have limited therapeutic options and poor outcomes in part because their TCLs evade apoptosis through upregulation of anti-apoptotic Bcl-2 proteins. Subsets of TCL cell lines, patient-derived xenografts (PDXs), and primary patient samples depend on Bcl-xL for survival. However, small molecule Bcl-xL inhibitors such as ABT263 have failed during clinical development due to on-target and dose-limiting thrombocytopenia. We have developed DT2216, a proteolysis targeting chimera (PROTAC) targeting Bcl-xL for degradation via Von Hippel-Lindau (VHL) E3 ligase, and shown that it has better anti-tumor activity but is less toxic to platelets compared to ABT263. Here, we examined the therapeutic potential of DT2216 for TCLs via testing its anti-TCL activity in vitro using MTS assay, immunoblotting, and flow cytometry and anti-TCL activity in vivo using TCL cell xenograft and PDX model in mice. The results showed that DT2216 selectively killed various Bcl-xL-dependent TCL cells including MyLa cells in vitro. In vivo, DT2216 alone was highly effective against MyLa TCL xenografts in mice without causing significant thrombocytopenia or other toxicity. Furthermore, DT2216 combined with ABT199 (a se...Continue Reading

References

Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
May 11, 2002·Nature Reviews. Cancer·Frederik H Igney, Peter H Krammer
Jan 6, 2007·Cell Death and Differentiation·H ZhangC Tse
Mar 27, 2007·Cell·Kylie D MasonBenjamin T Kile
May 3, 2008·Cancer Research·Christin TseSteven W Elmore
Apr 24, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Vivien MakKerry J Savage
Mar 13, 2014·Blood·Alison J MoskowitzSteven M Horwitz
Jul 24, 2014·Cancer Chemotherapy and Pharmacology·Aksana KaeferHao Xiong
Jun 3, 2015·ACS Chemical Biology·Michael ZengerleAlessio Ciulli
Jun 9, 2015·Chemistry & Biology·Jing LuCraig M Crews
Jun 16, 2015·Nature Chemical Biology·Daniel P BondesonCraig M Crews
Jun 24, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Owen A O'ConnorAndrei Shustov
Aug 19, 2015·Nature Chemical Biology·Raymond J Deshaies
Nov 13, 2015·Current Cancer Drug Targets·Nobumichi OhokaMikihiko Naito
Nov 26, 2015·Angewandte Chemie·Ashton C LaiCraig M Crews
Apr 19, 2016·Immunological Reviews·Diana PassaroJacques Ghysdael
Jun 9, 2016·Proceedings of the National Academy of Sciences of the United States of America·Kanak RainaKevin G Coleman
Jul 17, 2016·Current Opinion in Chemical Biology·Andrew C RuncieAlessio Ciulli
Nov 26, 2016·Nature Reviews. Drug Discovery·Ashton C Lai, Craig M Crews
Feb 1, 2017·Leukemia & Lymphoma·Prithviraj BoseMarina Konopleva
Nov 14, 2017·Cell Chemical Biology·Hai-Tsang HuangNathanael S Gray
Dec 1, 2018·Blood·Raphael KochDavid M Weinstock
Dec 7, 2018·Hematology·Eric D Jacobsen, David M Weinstock
Jan 1, 2019·Cell Chemical Biology·Matthias BrandGeorg E Winter
Jan 19, 2019·Nature Reviews. Molecular Cell Biology·Rumani SinghKristopher Sarosiek
Jan 30, 2019·Aging·Wen LiDaohong Zhou
Dec 4, 2019·Nature Medicine·Sajid KhanDaohong Zhou

❮ Previous
Next ❯

Citations

Feb 16, 2021·Frontiers in Molecular Biosciences·Diana L BonillaEdmond Chua
Apr 12, 2021·The Journal of Biological Chemistry·Shanique B Alabi, Craig M Crews
Jun 1, 2021·Current Opinion in Pharmacology·Joel O Cresser-BrownHannah J Maple
May 19, 2021·Cell Chemical Biology·Kusal T G Samarasinghe, Craig M Crews
Aug 23, 2021·Drug Discovery Today·Scott J HughesIan Churcher
Sep 14, 2021·Biochemical Society Transactions·Erinna F Lee, W Douglas Fairlie
Sep 18, 2021·Journal of Medicinal Chemistry·Pratik PalGuangrong Zheng

❮ Previous
Next ❯

Datasets Mentioned

BETA
ABT199

Methods Mentioned

BETA
xenografts
xenograft
flow cytometry
protein assay
electrophoresis
PCR
xenografting

Software Mentioned

GraphPad
GraphPad Prism
ImageJ
Compusyn

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis